CDK6 and neoplasm: MiR-1180 is reported as a tumor suppressive miRNA in bladder cancer cells and inhibits cell proliferation and tumorigenicity by inhibiting cell cycle related proteins including CDK4, CDK6, cyclinD1, cyclinA2 expression and up-regulating p21 expression [15].